Hye Jin Kang - Concepedia

Author

Hye Jin Kang

Ulsan College ORCID

Also Known As

H J Kang, H. Kang, H.J. Kang, Hye J KANG, Hye J Kang, Hye Jin Kang, Jong-Mu Sun, Kang H

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Ulsan College University of Ulsan Asan Medical Center Korea Institute of Radiological and Medical Sciences Sungkyunkwan University

About

Hye Jin Kang is an author at Ulsan College specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	334
2	Gastroenterology	4	4	72
3	Pathology	4	4	185
4	Health Sciences	1	1	23
5	Immunology	1	1	14

Hye Jin Kang

Publications

580

Citations

H-Index

Page 1

	Year	Citations
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer Jia-Lin Lee, Y-K. Kang, Hye Jin Kang, British Journal of Cancer	2008	136
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer Chul Kim, Jae‐Lyun Lee, Min‐Hee Ryu, Investigational New Drugs Gastrointestinal OncologyMedicineCancer ManagementPathologyGastric Cancer	2009	82
EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil Im Il Na, Hye Jin Kang, Soo Youn Cho, European Journal of Cancer Tumor BiologyHuman PapillomavirusSquamous Cell CarcinomaEar MoldingPathology	2007	78
<i>Chlamydia psittaci</i> infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea Changhoon Yoo, Min‐Hee Ryu, Jooryung Huh, American Journal of Hematology	2007	69
Consideration of aggressive therapeutic strategies for primary testicular lymphoma Byeong‐Bae Park, Jong Gwang Kim, Sang Kyun Sohn, American Journal of Hematology Prophylactic Intrathecal ChemotherapyNeuro-oncologyLymphoid NeoplasiaSurgical OncologyUrology	2007	43
A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer Sun Jin Sym, Heung Moon Chang, Hye Jin Kang, Cancer Chemotherapy and Pharmacology Gastrointestinal OncologyMedicinePhase Ii StudyPharmacotherapySurgery	2008	31
Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer Jae‐Lyun Lee, Hye Jin Kang, Yoon‐Koo Kang, Cancer Chemotherapy and Pharmacology Surgical OncologyGastrointestinal OncologyPhase I/ii StudyRecurrent Gastric CancerMedicine	2007	27
Shear wave elastography for the diagnosis of small (≤2 cm) breast lesions: added value and factors associated with false results Hye Young Choi, Mirinae Seo, Yu‐Mee Sohn, British Journal of Radiology	2019	27
Radiologic serosal invasion sign as a new criterion of T4a gastric cancer on computed tomography: diagnostic performance and prognostic significance in patients with advanced gastric cancer Myung‐Won You, Soyoung Park, Hye Jin Kang, Abdominal Radiology Gastrointestinal OncologyAdvanced Gastric CancerMedicineT4a Gastric CancerAbdominal Imaging	2019	23
Prognostic Significance of Pretreatment <sup>18</sup>F-FDG PET/CT in Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma Treated by Radioimmunotherapy Using <sup>131</sup>I-Rituximab Ilhan Lim, Joon Yeun Park, Hye Jin Kang, Acta Haematologica	2013	14

Page 1